M12.259

Clinical Causes: The exact cause of PVNS remains unknown, but it is believed to involve abnormal proliferation of synovial cells. Some theories suggest it could be related to recurrent joint hemorrhages or inflammation. Genetic factors may play a role, with some evidence pointing toward neoplastic (tumor-like) processes. Environmental factors or injury are rarely associated but have been considered in individual cases.

Key Symptoms: Joint pain that worsens with activity or over time Swelling around the affected hip joint Stiffness or decreased range of motion in the hip A sensation of grinding or catching during movement Localized tenderness over the joint Possible a feeling of instability or weakness in the hip In advanced stages, muscle wasting or limping may occur

Diagnosis Path: Diagnosing PVNS of the hip involves a combination of clinical assessment and imaging studies. Typically, the process includes: - **Physical Examination:** A healthcare provider assesses joint swelling, tenderness, and range of motion. - **Imaging Tests:** - *Magnetic Resonance Imaging (MRI):* The most effective modality for detecting PVNS, revealing characteristic dark pigmented synovial tissue due to hemosiderin deposits. - *X-rays:* May show joint space narrowing or soft tissue swelling but are less specific. - **Biopsy:** Confirmatory diagnosis is often obtained through a tissue sample during arthroscopy or open surgery, revealing characteristic nodular synovial proliferation with pigmented deposits. Early and accurate diagnosis is crucial to prevent joint damage and plan appropriate treatment.

Treatment Protocols: Management of pigmented villonodular synovitis of the hip typically involves the following approaches: - **Surgical Removal:** The primary treatment involves arthroscopic or open synovectomy to excise abnormal synovial tissue. Complete removal is critical to reduce recurrence risk. - **Radiation Therapy:** In some cases, postoperative radiotherapy may be used to control residual disease or prevent recurrence. - **Medication:** Currently, no specific medications are approved for PVNS, but research is ongoing into targeted therapies. - **Rehabilitation:** Postoperative physical therapy aims to restore joint function, strength, and mobility. - **Monitoring:** Regular follow-up with imaging is necessary to detect any recurrence early. The prognosis varies depending on the extent of disease and success of surgical removal, but with proper treatment, many patients experience relief from symptoms and improved joint function.